{"id":"W1949811104","doi":"10.1200/jco.2001.19.2.314","title":"Phase II Study of Docetaxel, Doxorubicin, and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer","year":2001,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"ca_institutions":"Saskatchewan Cancer Agency","funders":"","keywords":"Medicine; Docetaxel; Metastatic breast cancer; Neutropenia; Cyclophosphamide; Febrile neutropenia; Internal medicine; Chemotherapy; Doxorubicin; Regimen; Breast cancer; Surgery; Phases of clinical research; Gastroenterology; Adverse effect; Cancer; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001917312,0.00145967,0.001894387,0.0004859095,0.0003905273,0.0007137294,0.001161052,0.001001682,0.002826396],"category_scores_gemma":[0.001151894,0.0006443795,0.00095996,0.0005025314,0.0008610496,0.0005128403,0.000332281,0.002491311,0.00073635],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009359546,"about_ca_system_score_gemma":0.002263726,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001407921,"about_ca_topic_score_gemma":0.003953923,"domain_scores_codex":[0.9993889,0.0003159312,0.00003119952,0.0000812967,0.00007497278,0.0001076846],"domain_scores_gemma":[0.9989697,0.0001580092,0.0001823141,0.00007256956,0.00007338657,0.0005440938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5388916,0.2301251,0.01444554,0.001302638,0.001495573,0.0007882439,0.0003790026,0.003713315,0.07662302,0.0002394394,0.00461015,0.1273865],"study_design_scores_gemma":[0.512972,0.4655676,0.01182604,0.0000432797,0.0003402527,0.000453949,0.00003655292,0.001021464,0.004892633,0.00007265049,0.002753237,0.00002033171],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905172,0.002947989,0.0006854861,0.0003327371,0.0001718065,0.003789495,0.000521427,0.00008073099,0.0009531471],"genre_scores_gemma":[0.981117,0.002704873,0.004151252,0.0009451654,0.0002892813,0.005149251,0.002860066,0.00002904823,0.002754087],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002826396,"threshold_uncertainty_score":0.01013988,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1341035759241524,"score_gpt":0.5424805441816323,"score_spread":0.4083769682574799,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}